- Home
- GOSS vs BWMX Comparison
GOSS vs BWMX Comparison
Compare GOSS & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- BWMX
- Stock Information
- Founded
- GOSS 2015
- BWMX 1995
- Country
- GOSS United States
- BWMX Mexico
- Employees
- GOSS N/A
- BWMX N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- BWMX Catalog/Specialty Distribution
- Sector
- GOSS Health Care
- BWMX Consumer Discretionary
- Exchange
- GOSS Nasdaq
- BWMX Nasdaq
- Market Cap
- GOSS 347.8M
- BWMX 495.6M
- IPO Year
- GOSS 2019
- BWMX N/A
- Fundamental
- Price
- GOSS $2.47
- BWMX $13.29
- Analyst Decision
- GOSS Strong Buy
- BWMX Strong Buy
- Analyst Count
- GOSS 4
- BWMX 1
- Target Price
- GOSS $8.50
- BWMX $22.50
- AVG Volume (30 Days)
- GOSS 3.1M
- BWMX 55.5K
- Earning Date
- GOSS 08-05-2025
- BWMX 10-23-2025
- Dividend Yield
- GOSS N/A
- BWMX 10.75%
- EPS Growth
- GOSS N/A
- BWMX N/A
- EPS
- GOSS N/A
- BWMX 0.84
- Revenue
- GOSS $40,237,000.00
- BWMX $751,432,052.00
- Revenue This Year
- GOSS N/A
- BWMX $6.54
- Revenue Next Year
- GOSS $30.65
- BWMX $6.09
- P/E Ratio
- GOSS N/A
- BWMX $15.88
- Revenue Growth
- GOSS N/A
- BWMX 4.83
- 52 Week Low
- GOSS $0.66
- BWMX $7.00
- 52 Week High
- GOSS $2.65
- BWMX $14.46
- Technical
- Relative Strength Index (RSI)
- GOSS 68.08
- BWMX 62.09
- Support Level
- GOSS $2.38
- BWMX $13.06
- Resistance Level
- GOSS $2.65
- BWMX $13.50
- Average True Range (ATR)
- GOSS 0.15
- BWMX 0.45
- MACD
- GOSS 0.03
- BWMX -0.13
- Stochastic Oscillator
- GOSS 76.67
- BWMX 66.64
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.